Comparative User Experiences With BD Nano™ PRO 32G Extra Thin Wall Pen Needle vs the Terumo Nanopass® 34G Pen Needle
Clinical trial NCT03878745 · COMPLETED
Trial details
- NCT number
- NCT03878745
- Sponsor
- Becton, Dickinson and Company
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-11
- Primary completion
- 2019-06-14
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.